Yonsei University
Yonsei University
Explore linked clinical trials.213 results ยท Page 1 of 9
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCA | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Not yet recruiting | Not stated | 2026-10-09 | NCT07869602 | |
| Gangwon PCI Prospective Registry | Angina Pectoris, Arterial Occlusive Diseases, Chest Pain, Infarction, Necrosis, Neurologic Manifestations, Non-ST Elevated Myocardial Infarction, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Prinzmetal angina, ST-elevation myocardial infarction, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, intermediate coronary syndrome, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2026-10-07 | NCT02038127 | |
| An Intervention to Reduce Sedentary Behavior and Promote Physical Activity in Colorectal Cancer Chemotherapy | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Not yet recruiting | Not applicable | 2026-09-29 | NCT07845877 | |
| Lenvatinib in Patients With Advanced Parathyroid Carcinoma | Head and Neck Neoplasms, Neoplasms by Site, Parathyroid Neoplasms, endocrine system disorder, malignant endocrine neoplasm, neoplasm, parathyroid gland carcinoma, parathyroid gland disorder | Not yet recruiting | Phase 2 | 2026-09-28 | NCT07843901 | |
| Prospective Evaluation of AI Generated History of Present Illness Drafts in the Emergency Department | Disease Attributes, Emergencies, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Not stated | 2026-09-22 | NCT07804407 | |
| Prognostic Value of Pulse Oximetry Differences | Dyspnea, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, respiratory system disorder | Recruiting | Not stated | 2026-09-17 | NCT07824414 | |
| Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-14 | NCT07817901 | |
| Venous Closure System After AF Ablation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Phase 4 | 2026-09-10 | NCT07814144 | |
| Coronary Access After Evolut FX Plus TAVI: Impact of Commissural Alignment and the Large-Cell Frame Design: ACCESS-FX+ Registry | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Not yet recruiting | Not stated | 2026-09-10 | NCT07813273 | |
| Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07804381 | |
| Procedural Endpoint in Left Bundle Branch Area Pacing: Conduction System Capture Versus LV Septal Capture | Arrhythmia, Sinus, Arrhythmias, Cardiac, Bradycardia, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Ventricular Dysfunction, atrioventricular block, atrioventricular dissociation, cardiomyopathy, cardiovascular disorder, heart disorder, progressive familial heart block, type 1A, sick sinus syndrome | Not yet recruiting | Not applicable | 2026-09-04 | NCT07804394 | |
| Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Not yet recruiting | Phase 2 | 2026-09-04 | NCT07640932 | |
| JIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI Failure | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 1 | 2026-09-02 | NCT07798921 | |
| Sacituzumab Govitecan and Q901 in Advanced TNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 2 | 2026-08-26 | NCT07788222 | |
| Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma | Locally Advanced Nasopharyngeal Carcinoma | Active, not recruiting | Phase 2 | 2026-08-24 | NCT04910347 | |
| Erector Spinae Oxygen Saturation and AKI After OPCAB | Arterial Occlusive Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Urogenital Diseases, acute kidney injury, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, kidney disorder, kidney failure, myocardial ischemia, urinary system disorder, vascular disorder | Not yet recruiting | Not stated | 2026-08-12 | NCT07760129 | |
| OptiCross HD IVUS for Assessing Invasion Depth in Upper Tract Urothelial Carcinoma | renal pelvis/ureter urothelial carcinoma | Not yet recruiting | Not applicable | 2026-08-07 | NCT07751796 | |
| Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Not stated | 2026-08-07 | NCT05782465 | |
| Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-07-29 | NCT06516679 | |
| Home-based Rehabilitation Monitoring System With Wearable Devices and Self-Report Application | Gait Disorders, Neurologic, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder | Active, not recruiting | Not applicable | 2026-07-27 | NCT06410755 | |
| Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure (Severance PFO Registry) | Arrhythmias, Cardiac, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, atrial septal defect, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, transient ischemic attack, vascular disorder | Recruiting | Not stated | 2026-07-23 | NCT07724171 | |
| HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, coronary artery disorder, heart disorder, heart failure, heart valve disorder, myocardial ischemia, peripheral arterial disease, peripheral vascular disease, systolic heart failure, vascular disorder | Not yet recruiting | Not applicable | 2026-07-23 | NCT07721584 | |
| Evaluate the Effectiveness and Safety of At-Home Rehabilitation Gait Training Using a Hip-assisted Wearable Robot in Stroke Patients | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-07-21 | NCT07716475 | |
| A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2026-07-14 | NCT07702851 | |
| Evaluation of the Effectiveness, Safety, and Cost of a Smart Hospital System for Patients With Chronic Obstructive Pulmonary Disease | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Not applicable | 2026-07-13 | NCT06601777 |